Figure 5
Figure 5. CD4+ TNs and TEMs require cognate interactions with MHCII+ mCP-CML cells to mediate GVL. B6 mice were irradiated and reconstituted with T cell–depleted B6bm12 BM, wt B6, or IAbβ−/− mCP-CML, with no T cells or with 5 × 105 TN or 106 TEM B6bm12 CD4 cells. (A) Survival data from 1 of 2 similar experiments; P = .002 for recipients of IAbβ−/− mCP-CML and TEMs versus wt B6 mCP-CML and TEMs; P = .004 comparing recipients of IAbβ−/− mCP-CML and TNs versus wt B6 mCP-CML and TNs. (B) Numbers of NGFR+ cells in the peripheral blood of mice that underwent transplantation taken at different time points. At day 9, peripheral blood was harvested from only 2 of 8 recipients of wt mCP-CML and TNs and 2 of 4 recipients of IAbβ−/− mCP-CML and TNs, as we were concerned that the remainder might not tolerate the procedure due to the severity of GVHD. Comparing recipients of wt mCP-CML and TNs versus TEMs, P < .04 on days 15, 22, and 39 and P > .3 on days 37 and 54. (C) Spleen weight of each recipient after death or killing at day + 50. P > .4 comparing spleen weights of recipients of IAbβ−/− mCP-CML and either TNs or TEMs versus no T cells; P < .008 comparing spleen weights of recipients of wt mCP-CML and either TNs or TEMs versus no T cells. Horizontal bars represent mean values.

CD4+ TNs and TEMs require cognate interactions with MHCII+ mCP-CML cells to mediate GVL. B6 mice were irradiated and reconstituted with T cell–depleted B6bm12 BM, wt B6, or IAbβ−/− mCP-CML, with no T cells or with 5 × 105 TN or 106 TEM B6bm12 CD4 cells. (A) Survival data from 1 of 2 similar experiments; P = .002 for recipients of IAbβ−/− mCP-CML and TEMs versus wt B6 mCP-CML and TEMs; P = .004 comparing recipients of IAbβ−/− mCP-CML and TNs versus wt B6 mCP-CML and TNs. (B) Numbers of NGFR+ cells in the peripheral blood of mice that underwent transplantation taken at different time points. At day 9, peripheral blood was harvested from only 2 of 8 recipients of wt mCP-CML and TNs and 2 of 4 recipients of IAbβ−/− mCP-CML and TNs, as we were concerned that the remainder might not tolerate the procedure due to the severity of GVHD. Comparing recipients of wt mCP-CML and TNs versus TEMs, P < .04 on days 15, 22, and 39 and P > .3 on days 37 and 54. (C) Spleen weight of each recipient after death or killing at day + 50. P > .4 comparing spleen weights of recipients of IAbβ−/− mCP-CML and either TNs or TEMs versus no T cells; P < .008 comparing spleen weights of recipients of wt mCP-CML and either TNs or TEMs versus no T cells. Horizontal bars represent mean values.

Close Modal

or Create an Account

Close Modal
Close Modal